We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Gold Nanoparticles Designed to Track Viruses

By LabMedica International staff writers
Posted on 30 Jan 2014
Finish scientists have developed a unique strategy for the study of Enterovirus structures and their biologic processes. More...
The new approach will help in obtaining new data on viruses functioning in cells and tissues as well as on the mechanisms of virus opening inside cells. This new information will be important, for instance, for developing new antiviral drugs and vaccines.

The study’s findings were published January 13, 2014, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS). The research, conducted by researchers at the Nanoscience Center (NSC) of the University of Jyväskylä (Finland), was funded by the Academy of Finland (Helsinki) and Tekes’ (Länsi-Pasila, Finland) FiDiPro project NOVAC (Novel Methods for Vaccination and Virus Detection).

The infection mechanisms and infectious pathways of enteroviruses are still rather poorly known. Earlier research from the group of NSC’s Dr. Varpu Marjomäki have centered on the cellular factors that are important for the infection caused by selected enteroviruses. The understanding of virus processes of opening and releasing the viral genome in cellular structures for starting new virus production is still mostly unknown. Moreover, the knowledge of infectious processes in tissues is restricted by the lack of effective tools for detecting virus infections.

The newly developed technique involves a chemical modification of a known thiol-stabilized gold nanoparticle, the so-called Au102 cluster, which was first synthesized and structurally deciphered by Dr. Roger D. Kornberg’s team, from Stanford University (Stanford, CA, USA), in 2007 and later characterized at the NSC by the groups of Prof. Hannu Häkkinen and Prof. Mika Pettersson in collaboration with Dr. Kornberg.

The organic thiol surface of the Au102 particles is modified by attaching linker molecules that make a chemical bond to sulfur-containing cysteine residues that are part of the surface structure of the virus. Several tens of gold particles can bind to a single virus, and the binding pattern looks like dark tags reflecting the overall shape and structure of the virus. The gold particles allow for studies on the structural changes of the viruses during their lifespan.

In addition, the study’s findings revealed that the viruses’ infection approach is not compromised by the attached gold particles, which indicates that the labelling strategy does not interfere with the normal biologic functions of viruses inside cells. This aids new research on the virus structures from samples gathered from inside cells during the various phases of the virus infection, and makes it possible to obtain new information on the mechanisms of virus uncoating.

The new technique, according to the researchers, also allows for tracking studies of virus pathways in tissues. This is significant for the further determination of acute and chronic symptoms caused by viruses. Finally, the method is expected to be useful for developing new antiviral vaccines based on virus-like particles.

The method was developed at the NSC as a wide, cross-disciplinary collaboration between physicists, chemists, and biologists.

Related Links:

University of Jyväskylä



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The discovery of early markers for ovarian cancer that would have improved sensitivity could aid detection (Photo courtesy of Adobe Stock)

Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis

Ovarian cancer is a deadly and challenging disease, primarily because early detection is difficult. Most women (70-75%) are diagnosed only after the cancer has already spread, which significantly reduces... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.